May 2, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced additional results from its completed Phase 3 SPOTLIGHT trial of 

May 2, 2023 — Metabolic disorders are involved in many common health conditions such as Alzheimer's, depression, diabetes, and

The digital pathology market today is rife with potential for investment and returns, potential for major shifts in competitive dynamics, and potential for vendors to have a real impact on the way pathologists work

News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest in December, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior.
We need to go further with the tools that will carry us into the next century — more sophisticated, data strategy-influenced robotics, augmented/virtual reality and smarter navigation systems.

Modalities used in spine surgery, like computed tomography (CT) scan-based navigation systems and even X-rays, reached a turning point in the last decade in terms of technological advancement. We saw developments in robotic surgery, computer-assisted navigation and advancement in minimally invasive surgeries.
AI-enhanced scanning provides a greater level of detail for MRI technologists and physicians.

Magnetic resonance imaging (MRI) is a technology that has been around for more than four decades and is a staple in healthcare. Like other long-established technologies, there have been ongoing improvements to MRI scans.

May 1, 2023 — Nano-X Imaging Ltd., an innovative medical imaging technology company, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the multi-source Nanox.ARC, including the Nanox.CLOUD, its accompanying cloud-based infrastructure. Nanox.ARC is a stationary X-ray system intended to produce tomographic images of the human musculoskeletal system adjunctive to conventional radiography on adult patients.

May 1, 2023 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced new results evaluating the decision impact for radiation therapy (RT) recommendations incorporating the 

May 1, 2023 — Artificial intelligence (AI) could help doctors diagnose lung cancer earlier, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research, London, and Imperial College London. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now